Immunological analysis of 140-kDa adenovirus-encoded DNA polymerase in adenovirus type 2-infected HeLa cells using antibodies raised against the protein expressed in Escherichia coli.
The E2B region of adenovirus genome contains a long open reading frame (ORF) extending from 24 to 14.2 map units which encodes most of the 140-kDa DNA polymerase. It was cloned at the polylinker region of pUC18 vector with Escherichia coli JM109 as the host. A clone was serendipitously isolated that expressed in E. coli a protein of approximately 120 kDa in size at high levels. DNA sequence analysis of this clone showed the presence of an in-frame fusion of a region, encoding 13 amino acids located upstream, to the first ATG of the ORF. Polyclonal antibodies raised against this protein purified from E. coli were used for immunological analysis. The antibodies were able to detect a 140- and a 66-kDa polypeptide from the adenovirus type 2-infected HeLa cells on Western blots. In addition, the antibodies showed evidence of cross-reactivity with partially purified DNA polymerase alpha from uninfected HeLa cells. The subcellular localization of the viral polymerase in the infected HeLa cells by using indirect immunofluorescence showed that the viral protein is associated with globular structures in the nucleus. The replicating viral DNA and the polymerase were colocalized in these globular sites. Furthermore, HeLa cells infected with Ad5ts149, a temperature-sensitive mutant defective in DNA replication, showed the presence of these globular sites only at the permissive temperature, suggesting that these sites are probably involved in viral DNA replication.
Sasaguri
Y
Y
Department of Biochemistry, University of Kansas Medical Center, Kansas City 66103.
Sanford
T
T
Aguirre
P
P
Padmanabhan
R
R
D000260:Adenoviruses, Human / Q000201:enzymology / Q000235:genetics / Q000276:immunology*; D000914:Antibodies, Viral / Q000276:immunology*; D000941:Antigens / Q000276:immunology*; D000956:Antigens, Viral / Q000276:immunology*; D002451:Cell Compartmentation; D003429:Cross Reactions; D004257:DNA Polymerase II / Q000276:immunology; D004259:DNA-Directed DNA Polymerase / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D004926:Escherichia coli; D005786:Gene Expression Regulation; D006367:HeLa Cells; D006801:Humans; D007163:Immunosorbent Techniques; D008970:Molecular Weight; D011993:Recombinant Fusion Proteins / Q000276:immunology; D011994:Recombinant Proteins / Q000235:genetics / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000276:immunology*
D000914:Antibodies, Viral; D000941:Antigens; D000956:Antigens, Viral; D011993:Recombinant Fusion Proteins; D011994:Recombinant Proteins; D014614:Vaccines, Synthetic; D004257:DNA Polymerase II; D004259:DNA-Directed DNA Polymerase